Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia.

Li W, Ghose S, Gleason K, Begovic A, Perez J, Bartko J, Russo S, Wagner AD, Selemon L, Tamminga CA.

Am J Psychiatry. 2015 Apr;172(4):373-82. doi: 10.1176/appi.ajp.2014.14010123. Epub 2015 Jan 13. Erratum in: Am J Psychiatry. 2015 May;172(5):488.

2.

Pregnanolone Glutamate, a Novel Use-Dependent NMDA Receptor Inhibitor, Exerts Antidepressant-Like Properties in Animal Models.

Holubova K, Nekovarova T, Pistovcakova J, Sulcova A, Stuchlík A, Vales K.

Front Behav Neurosci. 2014 Apr 16;8:130. doi: 10.3389/fnbeh.2014.00130. eCollection 2014.

3.

Heat shock alters the expression of schizophrenia and autism candidate genes in an induced pluripotent stem cell model of the human telencephalon.

Lin M, Zhao D, Hrabovsky A, Pedrosa E, Zheng D, Lachman HM.

PLoS One. 2014 Apr 15;9(4):e94968. doi: 10.1371/journal.pone.0094968. eCollection 2014.

4.

Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia.

Pietersen CY, Mauney SA, Kim SS, Lim MP, Rooney RJ, Goldstein JM, Petryshen TL, Seidman LJ, Shenton ME, McCarley RW, Sonntag KC, Woo TU.

J Neurogenet. 2014 Mar-Jun;28(1-2):53-69. doi: 10.3109/01677063.2014.882918. Epub 2014 Apr 10.

5.

Molecular profiles of parvalbumin-immunoreactive neurons in the superior temporal cortex in schizophrenia.

Pietersen CY, Mauney SA, Kim SS, Passeri E, Lim MP, Rooney RJ, Goldstein JM, Petreyshen TL, Seidman LJ, Shenton ME, Mccarley RW, Sonntag KC, Woo TU.

J Neurogenet. 2014 Mar-Jun;28(1-2):70-85. doi: 10.3109/01677063.2013.878339. Epub 2014 Mar 17.

6.

Hippocampal and amygdalar local structural differences in elderly patients with schizophrenia.

Prestia A, Cavedo E, Boccardi M, Muscio C, Adorni A, Geroldi C, Bonetti M, Thompson PM, Frisoni GB.

Am J Geriatr Psychiatry. 2015 Jan;23(1):47-58. doi: 10.1016/j.jagp.2014.01.006. Epub 2014 Jan 22.

7.

Personalized medicine in psychiatry: problems and promises.

Ozomaro U, Wahlestedt C, Nemeroff CB.

BMC Med. 2013 May 16;11:132. doi: 10.1186/1741-7015-11-132. Review.

8.

High-affinity nicotinic acetylcholine receptor expression and trafficking abnormalities in psychiatric illness.

Lewis AS, Picciotto MR.

Psychopharmacology (Berl). 2013 Oct;229(3):477-85. doi: 10.1007/s00213-013-3126-5. Epub 2013 Apr 28. Review.

9.

Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Kocsis B, Brown RE, McCarley RW, Hajos M.

CNS Neurosci Ther. 2013 Jun;19(6):437-47. doi: 10.1111/cns.12081. Epub 2013 Apr 24. Review.

10.
11.

Neurosteroids, stress and depression: potential therapeutic opportunities.

Zorumski CF, Paul SM, Izumi Y, Covey DF, Mennerick S.

Neurosci Biobehav Rev. 2013 Jan;37(1):109-22. doi: 10.1016/j.neubiorev.2012.10.005. Epub 2012 Oct 17. Review.

12.

Convergent functional genomic studies of ω-3 fatty acids in stress reactivity, bipolar disorder and alcoholism.

Le-Niculescu H, Case NJ, Hulvershorn L, Patel SD, Bowker D, Gupta J, Bell R, Edenberg HJ, Tsuang MT, Kuczenski R, Geyer MA, Rodd ZA, Niculescu AB.

Transl Psychiatry. 2011 Apr 26;1:e4. doi: 10.1038/tp.2011.1.

13.

Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction.

Ayalew M, Le-Niculescu H, Levey DF, Jain N, Changala B, Patel SD, Winiger E, Breier A, Shekhar A, Amdur R, Koller D, Nurnberger JI, Corvin A, Geyer M, Tsuang MT, Salomon D, Schork NJ, Fanous AH, O'Donovan MC, Niculescu AB.

Mol Psychiatry. 2012 Sep;17(9):887-905. doi: 10.1038/mp.2012.37. Epub 2012 May 15.

14.

Induction of the GABA cell phenotype: an in vitro model for studying neurodevelopmental disorders.

Subburaju S, Benes FM.

PLoS One. 2012;7(3):e33352. doi: 10.1371/journal.pone.0033352. Epub 2012 Mar 21.

15.

Kainate receptor-mediated modulation of hippocampal fast spiking interneurons in a rat model of schizophrenia.

Gisabella B, Bolshakov VY, Benes FM.

PLoS One. 2012;7(3):e32483. doi: 10.1371/journal.pone.0032483. Epub 2012 Mar 1.

16.

Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders.

Thompson Ray M, Weickert CS, Wyatt E, Webster MJ.

J Psychiatry Neurosci. 2011 May;36(3):195-203. doi: 10.1503/jpn.100048.

17.

Perisomatic GABAergic innervation in prefrontal cortex is regulated by ankyrin interaction with the L1 cell adhesion molecule.

Guan H, Maness PF.

Cereb Cortex. 2010 Nov;20(11):2684-93. doi: 10.1093/cercor/bhq016. Epub 2010 Feb 15.

18.

N-methyl-D-aspartate receptor expression in parvalbumin-containing inhibitory neurons in the prefrontal cortex in bipolar disorder.

Bitanihirwe BK, Lim MP, Woo TU.

Bipolar Disord. 2010 Feb;12(1):95-101. doi: 10.1111/j.1399-5618.2009.00785.x.

19.

Histone modifications, DNA methylation, and schizophrenia.

Gavin DP, Sharma RP.

Neurosci Biobehav Rev. 2010 May;34(6):882-8. doi: 10.1016/j.neubiorev.2009.10.010. Epub 2009 Oct 30. Review.

20.

How high-resolution basal-state functional imaging can guide the development of new pharmacotherapies for schizophrenia.

Gaisler-Salomon I, Schobel SA, Small SA, Rayport S.

Schizophr Bull. 2009 Nov;35(6):1037-44. doi: 10.1093/schbul/sbp114. Epub 2009 Oct 14.

Items per page

Supplemental Content

Write to the Help Desk